Electrically active immune-mediated rippling muscle disease preceding breast cancer

Teerin Liewluck, Brent P. Goodman, Margherita Milone

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

INTRODUCTION: Rippling muscle disease (RMD) is a rare disorder of muscle hyperexcitability clinically characterized by painful muscle stiffness, rippling phenomenon, percussion-induced muscle mounding, and rapid contraction. RMD is typically considered to be electrically silent, but electrical activity during the muscle rippling has been occasionally described. RMD could be genetically determined or immune-mediated (iRMD). The association between cancer and iRMD is extremely rare. CASE REPORT: We present here a patient with electrically active iRMD preceding the diagnosis of breast cancer. The patient had acetylcholine receptor binding antibodies but no clinical or electrophysiological signs of myasthenia. Muscle biopsy revealed inflammatory changes and a mosaic distribution of sarcolemmal caveolin-3 deficiency. Sequencing of caveolin-3 gene detected no mutation. Immunotherapy led to the resolution of the RMD and disappearance of the serum acetylcholine receptor antibodies. CONCLUSIONS: The abnormal electrical activity in this patient suggests that an acquired neuromuscular hyperexcitability syndrome represents a continuum of disorders. The close temporal relationship between the onset of iRMD and the diagnosis of breast cancer raises the possibility that iRMD might be paraneoplastic.

Original languageEnglish (US)
Pages (from-to)155-158
Number of pages4
JournalNeurologist
Volume18
Issue number3
DOIs
StatePublished - May 2012

Fingerprint

Caveolin 3
Breast Neoplasms
Muscles
Cholinergic Receptors
Percussion
Antibodies
Muscular Diseases
Immunotherapy
Biopsy
Mutation
1 Rippling muscle disease
Serum
Genes
Neoplasms

Keywords

  • caveolin-3
  • myasthenia gravis
  • paraneoplastic neurological disorders
  • rippling muscle disease

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Electrically active immune-mediated rippling muscle disease preceding breast cancer. / Liewluck, Teerin; Goodman, Brent P.; Milone, Margherita.

In: Neurologist, Vol. 18, No. 3, 05.2012, p. 155-158.

Research output: Contribution to journalArticle

Liewluck, Teerin ; Goodman, Brent P. ; Milone, Margherita. / Electrically active immune-mediated rippling muscle disease preceding breast cancer. In: Neurologist. 2012 ; Vol. 18, No. 3. pp. 155-158.
@article{d972f6aa13944c9ea4f6e4cd39aaae56,
title = "Electrically active immune-mediated rippling muscle disease preceding breast cancer",
abstract = "INTRODUCTION: Rippling muscle disease (RMD) is a rare disorder of muscle hyperexcitability clinically characterized by painful muscle stiffness, rippling phenomenon, percussion-induced muscle mounding, and rapid contraction. RMD is typically considered to be electrically silent, but electrical activity during the muscle rippling has been occasionally described. RMD could be genetically determined or immune-mediated (iRMD). The association between cancer and iRMD is extremely rare. CASE REPORT: We present here a patient with electrically active iRMD preceding the diagnosis of breast cancer. The patient had acetylcholine receptor binding antibodies but no clinical or electrophysiological signs of myasthenia. Muscle biopsy revealed inflammatory changes and a mosaic distribution of sarcolemmal caveolin-3 deficiency. Sequencing of caveolin-3 gene detected no mutation. Immunotherapy led to the resolution of the RMD and disappearance of the serum acetylcholine receptor antibodies. CONCLUSIONS: The abnormal electrical activity in this patient suggests that an acquired neuromuscular hyperexcitability syndrome represents a continuum of disorders. The close temporal relationship between the onset of iRMD and the diagnosis of breast cancer raises the possibility that iRMD might be paraneoplastic.",
keywords = "caveolin-3, myasthenia gravis, paraneoplastic neurological disorders, rippling muscle disease",
author = "Teerin Liewluck and Goodman, {Brent P.} and Margherita Milone",
year = "2012",
month = "5",
doi = "10.1097/NRL.0b013e318251e70f",
language = "English (US)",
volume = "18",
pages = "155--158",
journal = "Neurologist",
issn = "1074-7931",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Electrically active immune-mediated rippling muscle disease preceding breast cancer

AU - Liewluck, Teerin

AU - Goodman, Brent P.

AU - Milone, Margherita

PY - 2012/5

Y1 - 2012/5

N2 - INTRODUCTION: Rippling muscle disease (RMD) is a rare disorder of muscle hyperexcitability clinically characterized by painful muscle stiffness, rippling phenomenon, percussion-induced muscle mounding, and rapid contraction. RMD is typically considered to be electrically silent, but electrical activity during the muscle rippling has been occasionally described. RMD could be genetically determined or immune-mediated (iRMD). The association between cancer and iRMD is extremely rare. CASE REPORT: We present here a patient with electrically active iRMD preceding the diagnosis of breast cancer. The patient had acetylcholine receptor binding antibodies but no clinical or electrophysiological signs of myasthenia. Muscle biopsy revealed inflammatory changes and a mosaic distribution of sarcolemmal caveolin-3 deficiency. Sequencing of caveolin-3 gene detected no mutation. Immunotherapy led to the resolution of the RMD and disappearance of the serum acetylcholine receptor antibodies. CONCLUSIONS: The abnormal electrical activity in this patient suggests that an acquired neuromuscular hyperexcitability syndrome represents a continuum of disorders. The close temporal relationship between the onset of iRMD and the diagnosis of breast cancer raises the possibility that iRMD might be paraneoplastic.

AB - INTRODUCTION: Rippling muscle disease (RMD) is a rare disorder of muscle hyperexcitability clinically characterized by painful muscle stiffness, rippling phenomenon, percussion-induced muscle mounding, and rapid contraction. RMD is typically considered to be electrically silent, but electrical activity during the muscle rippling has been occasionally described. RMD could be genetically determined or immune-mediated (iRMD). The association between cancer and iRMD is extremely rare. CASE REPORT: We present here a patient with electrically active iRMD preceding the diagnosis of breast cancer. The patient had acetylcholine receptor binding antibodies but no clinical or electrophysiological signs of myasthenia. Muscle biopsy revealed inflammatory changes and a mosaic distribution of sarcolemmal caveolin-3 deficiency. Sequencing of caveolin-3 gene detected no mutation. Immunotherapy led to the resolution of the RMD and disappearance of the serum acetylcholine receptor antibodies. CONCLUSIONS: The abnormal electrical activity in this patient suggests that an acquired neuromuscular hyperexcitability syndrome represents a continuum of disorders. The close temporal relationship between the onset of iRMD and the diagnosis of breast cancer raises the possibility that iRMD might be paraneoplastic.

KW - caveolin-3

KW - myasthenia gravis

KW - paraneoplastic neurological disorders

KW - rippling muscle disease

UR - http://www.scopus.com/inward/record.url?scp=84861110322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861110322&partnerID=8YFLogxK

U2 - 10.1097/NRL.0b013e318251e70f

DO - 10.1097/NRL.0b013e318251e70f

M3 - Article

C2 - 22549359

AN - SCOPUS:84861110322

VL - 18

SP - 155

EP - 158

JO - Neurologist

JF - Neurologist

SN - 1074-7931

IS - 3

ER -